RNA, U6 small nuclear 1009, pseudogene (RNU6-1009P)

RNU6-1009P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene, a component originally involved in nuclear pre-mRNA splicing within the spliceosome complex[6][4][5]. Unlike the canonical U6 snRNA, which forms part of a ribonucleoprotein essential for excising introns from pre-mRNAs in eukaryotes[1][3], the RNU6-1009P pseudogene is an inactive genomic copy. It likely arose via L1 retrotransposition—an event where RNA is reverse-transcribed and inserted back into the genome, often accompanied by mutations or truncations that render it non-functional[4][5]. Pseudogenes such as RNU6-1009P are not transcribed into mature, functional RNA and do not code for proteins, nor do they participate in typical biological or pathological processes. There are no established roles for RNU6-1009P in disease, signaling, drug interactions, or as biomarkers[6][4]. In summary, it is not a receptor, enzyme, transporter, or conventional therapeutic target, but rather a non-functional genomic remnant with no known roles in biology or medicine.

Other names

RNU6-1009PRNA, U6 small nuclear 1009, pseudogene

None